Rockefeller Capital Management
FLGT icon

Rockefeller Capital Management’s Fulgent Genetics FLGT Stock Holding History

Rockefeller Capital Management’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-512
Closed -$8.14K – 4780
2026
Q1 		$8.14K Buy
512
+412
+412% +$8.94K ﹤0.01% 4079
2025
Q4 		$2.63K Hold
100
– – ﹤0.01% 4252
2025
Q3 		$2.26K Buy
+100
New +$2.06K ﹤0.01% 4064
2023
Q1 		– Sell
-2,094
Closed -$62K – 2637
2022
Q4 		$62K Sell
2,094
-54
-3% -$1.93K ﹤0.01% 2271
2022
Q3 		$81K Buy
2,148
+1,972
+1,120% +$98.9K ﹤0.01% 2106
2022
Q2 		$9K Sell
176
-160
-48% -$8.79K ﹤0.01% 3166
2022
Q1 		$20K Sell
336
-945
-74% -$62.2K ﹤0.01% 2717
2021
Q4 		$128K Buy
1,281
+18
+1% +$1.58K ﹤0.01% 1827
2021
Q3 		$113K Buy
1,263
+71
+6% +$6.45K ﹤0.01% 1806
2021
Q2 		$109K Sell
1,192
-13,225
-92% -$1.06M ﹤0.01% 1764
2021
Q1 		$1.39M Buy
14,417
+82
+0.6% +$8.46K 0.01% 685
2020
Q4 		$746K Buy
+14,335
New +$599K 0.01% 779

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Rockefeller Capital Management's FLGT Position: Q2 2026 in Review

Rockefeller Capital Management sold out of Fulgent Genetics (FLGT) in Q2 2026, closing a stake of 512 shares — an estimated $8.14K sold.

Rockefeller Capital Management first reported a position in FLGT in Q4 2020 and held it in 12 quarters. The position peaked at $1.39M in Q1 2021. 141 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

  • Rockefeller Capital Management reported no remaining Fulgent Genetics position as of Q2 2026 after selling out during the quarter.
  • Rockefeller Capital Management sold 512 Fulgent Genetics shares in Q2 2026, an estimated $8.14K.
  • Rockefeller Capital Management first reported a position in Fulgent Genetics in Q4 2020 and held it in 12 quarters.
  • Rockefeller Capital Management's Fulgent Genetics position peaked at $1.39M in Q1 2021.
  • 141 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.